Prospective epidemiological studies have found increased risk of incident or recurrent coronary heart disease (CHD) associated with higher baseline levels of sICAM-1 and MCP-1 [15-18], but it is unclear whether sICAM-1 and MCP-1 reflect the burden of subclinical coronary atherosclerosis. The gene discussed is CCL2; the disease is coronary atherosclerosis.